Autopsy report · NCT06298487
Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area
Cause of deathOther
“There is no longer any point in continuing the research, as the objectives and evaluation criteria defined in the protocol are now being evaluated in everyday practice.”
Life of this trial
- Ran for about 11 months before it stopped.
- 88 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Hôpital NOVO
- Sponsor type
- University, hospital or other
- Conditions
- COPD
- Interventions
- Patient questionnaires
- Participants
- 88
- Sites
- 1
- Countries
- France
Trials that died the same way
- Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease
“Following a reassessment, it was concluded that continuation of the study would no longer achieve its scientific objectives originally set out for the study.” - Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
“Per protocol, the study was terminated based on interim analysis results” - Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
“The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522)” - Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery
“The study was terminated on the basis that protocol defined stopping criteria had been met.” - Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
“Protocol review had expired and the study had previously been Suspended. There was no funding to continue the study.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.